top of page
Browse by category
Search


Significant increase of weight loss drugs before bariatric surgery
There has been a 16-fold increase in the use of weight loss drugs among patients before metabolic and bariatric surgery, signalling an...


MBS associated with significant reductions in the rates of adverse hepatic and extrahepatic outcomes in patients with steatotic liver disease
In patients with steatotic liver disease (SLD), metabolic bariatric surgery (MBS) is associated with significant reductions in the rates...


MBS for weight loss shows greater long-term benefits than GLP-1 medicines
A large Cleveland Clinic study has found that people with obesity and type 2 diabetes who undergo metabolic and bariatric surgery (MBS)...


GLP-1 drugs shown cost-effective for knee osteoarthritis and obesity, but MBS may be the best option from a clinical and economic perspective
A study led by investigators at Mass General Brigham has found that adding semaglutide and tirzepatide to usual care represents a...


Eating disorders are highly prevalent among Egyptian MBS patients
Eating disorders (EDs) are highly prevalent among metabolic bariatric surgery (MBS) patients, with binge eating disorder (BED) being the...


MBS patients have a greater risk for multiple cancer types compared with the general population
All-cancer incidence risk is similar between patients who underwent metabolic and bariatric surgery (MBS) and the general population,...


Journal Watch 2/7/2025
Welcome to our regular round-up of the latest bariatric and obesity-related papers published in the medical literature. As ever, we have...


International expert consensus statements on surgery for T2DM
An International panel of experts has published 43 statements on the nature, terminology and mechanisms of action of metabolic and...


BRIDGE Study: Bariatric surgery as a bridge to facilitate neoplastic/cancer surgery
Metabolic and bariatric surgery (MBS) offers a promising role as a transformative procedure prior to neoplastic therapy for patients...


Factors influencing pharmacokinetic changes following restrictive and metabolic bariatric surgery
Pharmacokinetic (PK) changes following both restrictive and metabolic bariatric surgery are drug-specific and highly variable according...
Browse by tag






bottom of page

